MEDICINES CO's ticker is and the CUSIP is 584688AE5. A total of 36 filers reported holding MEDICINES CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $7,585,000 | +25.9% | 5,000,000 | 0.0% | 0.38% | +64.9% |
Q2 2019 | $6,027,000 | +20.7% | 5,000,000 | 0.0% | 0.23% | -34.5% |
Q1 2019 | $4,992,000 | +15.4% | 5,000,000 | 0.0% | 0.35% | +116.1% |
Q4 2018 | $4,325,000 | -19.5% | 5,000,000 | 0.0% | 0.16% | -34.8% |
Q3 2018 | $5,376,000 | -11.5% | 5,000,000 | 0.0% | 0.25% | -15.4% |
Q2 2018 | $6,073,000 | +5.4% | 5,000,000 | 0.0% | 0.29% | +12.3% |
Q1 2018 | $5,762,000 | +8.8% | 5,000,000 | 0.0% | 0.26% | +2.4% |
Q4 2017 | $5,297,000 | -16.2% | 5,000,000 | 0.0% | 0.25% | +6.7% |
Q3 2017 | $6,324,000 | -2.9% | 5,000,000 | 0.0% | 0.24% | +12.8% |
Q2 2017 | $6,511,000 | -17.6% | 5,000,000 | 0.0% | 0.21% | -3.7% |
Q1 2017 | $7,897,000 | +31.1% | 5,000,000 | 0.0% | 0.22% | +112.6% |
Q4 2016 | $6,022,000 | -6.9% | 5,000,000 | 0.0% | 0.10% | -14.9% |
Q3 2016 | $6,469,000 | +9.0% | 5,000,000 | 0.0% | 0.12% | +53.2% |
Q2 2016 | $5,934,000 | +4.3% | 5,000,000 | 0.0% | 0.08% | -16.0% |
Q1 2016 | $5,688,000 | – | 5,000,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 3,588,000 | $4,370,000 | 3.61% |
Cheyne Capital Management (UK) LLP | 3,000,000 | $3,654,000 | 2.60% |
Myriad Asset Management Ltd. | 15,000,000 | $18,240,000 | 2.53% |
DLD Asset Management, LP | 22,500,000 | $27,506,000 | 2.07% |
SILVERBACK ASSET MANAGEMENT LLC | 11,000,000 | $13,379,000 | 1.70% |
BASSO CAPITAL MANAGEMENT, L.P. | 3,841,000 | $4,662,000 | 0.89% |
TFG Asset Management GP Ltd | 5,000,000 | $6,148,000 | 0.84% |
WOLVERINE ASSET MANAGEMENT LLC | 51,660,000 | $62,769,000 | 0.81% |
Weiss Asset Management LP | 5,000,000 | $6,142,000 | 0.61% |
City Financial Investment Co Ltd | 7,500,000 | $9,073,000 | 0.46% |